272 related articles for article (PubMed ID: 25487620)
1. The effectiveness of cognitive behavioral group psychotherapy for obsessive-compulsive disorder.
Safak Y; Karadere ME; Ozdel K; Ozcan T; Türkçapar MH; Kuru E; Yücens B
Turk Psikiyatri Derg; 2014; 25(4):225-33. PubMed ID: 25487620
[TBL] [Abstract][Full Text] [Related]
2. Predicting the therapeutic response to cognitive behavioural therapy in patients with pharmacoresistant obsessive-compulsive disorder.
Prasko J; Raszka M; Adamcova K; Grambal A; Koprivova J; Kudrnovská H; Latalova K; Vyskocilová J
Neuro Endocrinol Lett; 2009; 30(5):615-23. PubMed ID: 20035255
[TBL] [Abstract][Full Text] [Related]
3. Outcome of Intensive Cognitive Behaviour Therapy in a Residential Setting for People with Severe Obsessive Compulsive Disorder: A Large Open Case Series.
Veale D; Naismith I; Miles S; Childs G; Ball J; Muccio F; Darnley S
Behav Cogn Psychother; 2016 May; 44(3):331-46. PubMed ID: 26122913
[TBL] [Abstract][Full Text] [Related]
4. Alterations of responsibility beliefs through cognitive-behavioural group therapy for obsessive-compulsive disorder.
Haraguchi T; Shimizu E; Ogura H; Fukami G; Fujisaki M; Iyo M
Behav Cogn Psychother; 2011 Jul; 39(4):481-6. PubMed ID: 21338534
[TBL] [Abstract][Full Text] [Related]
5. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
[TBL] [Abstract][Full Text] [Related]
6. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist.
Storch EA; Larson MJ; Price LH; Rasmussen SA; Murphy TK; Goodman WK
J Anxiety Disord; 2010 Aug; 24(6):650-6. PubMed ID: 20471199
[TBL] [Abstract][Full Text] [Related]
7. Patient Rating of Therapeutic Factors and Response to Cognitive-Behavioral Group Therapy in Patients with Obsessive-Compulsive Disorder.
Behenck AS; Gomes JB; Heldt E
Issues Ment Health Nurs; 2016 Jun; 37(6):392-9. PubMed ID: 27105227
[TBL] [Abstract][Full Text] [Related]
8. Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist.
Sulkowski ML; Storch EA; Geffken GR; Ricketts E; Murphy TK; Goodman WK
J Clin Psychol; 2008 Dec; 64(12):1338-51. PubMed ID: 18942133
[TBL] [Abstract][Full Text] [Related]
9. Hoarding symptoms and prediction of poor response to limbic system surgery for treatment-refractory obsessive-compulsive disorder.
Gentil AF; Lopes AC; Dougherty DD; Rück C; Mataix-Cols D; Lukacs TL; Canteras MM; Eskandar EN; Larsson KJ; Hoexter MQ; Batistuzzo MC; Greenberg BD; Miguel EC
J Neurosurg; 2014 Jul; 121(1):123-30. PubMed ID: 24702323
[TBL] [Abstract][Full Text] [Related]
10. Behavioural group therapy for obsessive-compulsive disorder in Norway. An open community-based trial.
Håland AT; Vogel PA; Lie B; Launes G; Pripp AH; Himle JA
Behav Res Ther; 2010 Jun; 48(6):547-54. PubMed ID: 20359692
[TBL] [Abstract][Full Text] [Related]
11. Convergent and discriminant validity of the Yale-Brown Obsessive-Compulsive Scale Symptom Checklist.
Mataix-Cols D; Fullana MA; Alonso P; Menchón JM; Vallejo J
Psychother Psychosom; 2004; 73(3):190-6. PubMed ID: 15031592
[TBL] [Abstract][Full Text] [Related]
12. No talking, just writing! Efficacy of an Internet-based cognitive behavioral therapy with exposure and response prevention in obsessive compulsive disorder.
Herbst N; Voderholzer U; Thiel N; Schaub R; Knaevelsrud C; Stracke S; Hertenstein E; Nissen C; Külz AK
Psychother Psychosom; 2014; 83(3):165-75. PubMed ID: 24732962
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of pure obsessive-compulsive disorder.
Torres AR; Shavitt RG; Torresan RC; Ferrão YA; Miguel EC; Fontenelle LF
Compr Psychiatry; 2013 Oct; 54(7):1042-52. PubMed ID: 23746710
[TBL] [Abstract][Full Text] [Related]
14. Psychopathological and peripheral levels of neurobiological correlates of obsessive-compulsive symptoms in patients with epilepsy: a hospital-based study.
Hamed SA; Elserogy YM; Abd-Elhafeez HA
Epilepsy Behav; 2013 May; 27(2):409-15. PubMed ID: 23541859
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in the phenotypic expression of obsessive-compulsive disorder: an exploratory study from Brazil.
Torresan RC; Ramos-Cerqueira AT; de Mathis MA; Diniz JB; Ferrão YA; Miguel EC; Torres AR
Compr Psychiatry; 2009; 50(1):63-9. PubMed ID: 19059516
[TBL] [Abstract][Full Text] [Related]
16. Bipolar obsessive-compulsive disorder and personality disorders.
Maina G; Albert U; Pessina E; Bogetto F
Bipolar Disord; 2007 Nov; 9(7):722-9. PubMed ID: 17988362
[TBL] [Abstract][Full Text] [Related]
17. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in obsessive-compulsive disorder patients.
Kawano A; Tanaka Y; Ishitobi Y; Maruyama Y; Ando T; Inoue A; Okamoto S; Imanaga J; Kanehisa M; Higuma H; Ninomiya T; Tsuru J; Akiyoshi J
Psychiatry Res; 2013 Aug; 209(1):85-90. PubMed ID: 23266021
[TBL] [Abstract][Full Text] [Related]
18. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
Rosario-Campos MC; Miguel EC; Quatrano S; Chacon P; Ferrao Y; Findley D; Katsovich L; Scahill L; King RA; Woody SR; Tolin D; Hollander E; Kano Y; Leckman JF
Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
[TBL] [Abstract][Full Text] [Related]
19. Course of obsessive-compulsive disorder during early postpartum period: a prospective analysis of 16 cases.
Uguz F; Gezginc K; Zeytinci IE; Karatayli S; Askin R; Guler O; Sahin FK; Emul HM; Ozbulut O; Gecici O
Compr Psychiatry; 2007; 48(6):558-61. PubMed ID: 17954142
[TBL] [Abstract][Full Text] [Related]
20. Does cognitive-behavioral therapy response among adults with obsessive-compulsive disorder differ as a function of certain comorbidities?
Storch EA; Lewin AB; Farrell L; Aldea MA; Reid J; Geffken GR; Murphy TK
J Anxiety Disord; 2010 Aug; 24(6):547-52. PubMed ID: 20399603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
